Correction clarifies immunogenicity and safety of quadrivalent influenza vaccine and pneumococcal polysaccharide vaccine in chronic disease individuals.
A Correction on: Tang W, Lu X, Zhu Z, Yu D, Liu H, Song Y, Shen L, Yu Y, Zhao Y and Xie Y (2025) The immunogenicity and safety of an inactivated quadrivalent influenza vaccine and a 23-valent pneumococcal polysaccharide vaccine in individuals with chronic diseases. Front. Immunol. 16:1624095. doi: 10.3389/fimmu.2025.1624095 The Reviewer Ahmed Tawfik Moustafa's affiliation "Institut Pasteur de Paris, France" was erroneously given as "Institut Pasteur de Lille, France".The original version of this article has been updated.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: